Search clinical trials for: Iopromide

Total 21 results

Yong Huo

Unknown

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction (RIPE)

Kidney Failure, Chronic

China
Seoul National University Hospital

Completed

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Abdominal CT
GE Healthcare

Withdrawn

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Diabetes Mellitus | Renal Impairment | Coronary Artery Disease (CAD)

United States, Germany
University of Arizona

Terminated

An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer

Breast Cancer

United States
Seoul National University Bundang Hospital

Completed

Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide

Chronic Renal Insufficiency | Coronary Angiography

Korea, Republic of
Bayer

Completed

A Study to Learn More About the Safety of Ultravist in Children and in the Elderly

Hypersensitivity

Germany
Bayer

Completed

PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination (IMAGE)

Diagnostic Imaging

Poland, China, Germany, Hungary, Indonesia, Korea, Republic of, Malaysia, Saudi Arabia, Singapore, Thailand, Philippines, Taiwan, Italy, Moldova, Republic of, Romania, Russian Federation, Ukraine, Bosnia and Herzegovina, Pak... and more
Chinese PLA General Hospital

Completed

A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients (DIRECT)

Kidney Failure, Chronic

China
Bayer

Completed

Ultravist: Safety and Efficacy in Computed Tomography of Head and Body

Diagnostic Imaging | Computed Tomography

United States, Colombia, Korea, Republic of, India
Ospedale San Donato
Ospedale Le Scotte; Ospedale della Misericordia - Grosseto

Completed

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) (CONTRAST-AMI)

Acute Myocardial Infarction | Contrast Induced Nephropathy

Italy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Serum Thyroid Function After Iodinated Contrast Administration

Thyroid Dysfunction

China
Guerbet

Completed

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography (X-ACT)

Coronary Artery Disease

Spain, France, Germany, Italy, Switzerland
Bayer

Completed

A Study, Called UV Population, to Learn More About the Safety of the Study Drug Ultravist, Which is Given to Get Clearer X-ray Pictures, in People of Different Sexes, Races, and From Different Countries/Regions

Contrast Enhanced X-ray Based Examination

Germany
Seoul National University Hospital

Unknown

Role of Perfusion CT in Pancreatic Cancer

Neuroendocrine Carcinoma of Pancreas | Adenocarcinoma, Pancreas

Korea, Republic of
Bayer

Completed

A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting (RIGHT)

Multidetector Computed Tomography | Angiography

China
Bayer

Completed

Observational Study of Ultravist in Patients Requiring CECT (INDEX)

Diagnostic Imaging

China
Bayer

Completed

Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid (UVIA)

Contrast Medium

Germany
Bayer

Completed

The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST) (TRUST)

Angiocardiography

China
Medical University of South Carolina
Bayer

Completed

VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography (VOLCANIC-CTA)

Cardiovascular Diseases | Coronary Artery Disease

United States
GE Healthcare
Bayer; Guerbet/Liebel-Flarsheim

Withdrawn

Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

Hypothyroidism
University Hospital Ostrava

Completed

Treatment of Coronary In-Stent Restenosis (TIS)

Restenosis

Czechia

3

Subscribe